NCT00252941View on ClinicalTrials.gov

Prophylactic Urethral Stenting With Memokath After Prostate Implantation for Prostate Adenocarcinoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

April 30, 2006

Study Completion Date

November 30, 2006

Conditions
Prostate CancerPost-Brachytherapy Bladder Outlet Obstruction
Interventions
DEVICE

Memokath 028SW Urethral Stent

Trial Locations (1)

44195

Cleveland Clinic Foundation, Cleveland

All Listed Sponsors
lead

The Cleveland Clinic

OTHER

NCT00252941 - Prophylactic Urethral Stenting With Memokath After Prostate Implantation for Prostate Adenocarcinoma | Biotech Hunter | Biotech Hunter